Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastroesophageal Junction (GEJ) Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06157892
What this trial is testing

Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Who this might be right for
Breast NeoplasmsGastroesophageal Junction AdenocarcinomaHER2 Low Breast Neoplasms+7 more
Seagen, a wholly owned subsidiary of Pfizer 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT07068516
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Who this might be right for
Gastric Cancer Stage
Xiangdong Cheng 470
Testing effectiveness (Phase 2)Study completedNCT03861793
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

Who this might be right for
Advanced Solid Tumors
Mural Oncology, Inc 116
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Study completedNCT05379972
What this trial is testing

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

Who this might be right for
Gastric CancerGastroEsophageal Cancer
University of Colorado, Denver 9
Early research (Phase 1)Not Yet RecruitingNCT07333820
What this trial is testing

Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201

Who this might be right for
Malignant Neoplasm of Stomach, Unspecified
Yonsei University 18
Testing effectiveness (Phase 2)Temporarily pausedNCT06728657
What this trial is testing

Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma

Who this might be right for
Stomach AdenocarcinomaGastro-esophageal Junction Cancer
Fudan University 68
Testing effectiveness (Phase 2)Ended earlyNCT05071053
What this trial is testing

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

Who this might be right for
Adenocarcinoma GastricGastrooesophageal Cancer
Sanofi 35
Testing effectiveness (Phase 2)Study completedNCT07791329
What this trial is testing

Sequential FDG-PET and miRNA as Biomarkers of Preoperative Treatment Strategy in LA Oesophago-Gastric Cancer

Who this might be right for
Adenocarcinoma - Gastroesophageal Junction (GEJ)Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma
Masaryk Memorial Cancer Institute 144
Large-scale testing (Phase 3)Not Yet RecruitingNCT07700979
What this trial is testing

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso 900
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06871527
What this trial is testing

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

Who this might be right for
Gastric (Stomach) CancerGastric AdenocarcinomaFruquintinib+3 more
Sixth Affiliated Hospital, Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT05942573
What this trial is testing

Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Tianjin Medical University Cancer Institute and Hospital 107
Large-scale testing (Phase 3)Study completedNCT02661971
What this trial is testing

FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)

Who this might be right for
Stomach CancerGastroesophageal Junction Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 180
Large-scale testing (Phase 3)Study completedNCT04499924
What this trial is testing

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Seagen Inc. 17
Early research (Phase 1)Study completedNCT01386346
What this trial is testing

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Who this might be right for
Esophageal CancerMalignant Neoplasm of Cardio-esophageal Junction of Stomach
Weill Medical College of Cornell University 12
Large-scale testing (Phase 3)Study completedNCT03813784
What this trial is testing

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 885
Testing effectiveness (Phase 2)Study completedNCT01129310
What this trial is testing

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Who this might be right for
Gastrointestinal NeoplasmGastric Adenocarcinoma
AHS Cancer Control Alberta 47
Testing effectiveness (Phase 2)UnknownNCT05246982
What this trial is testing

HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Shanghai Henlius Biotech 40
Testing effectiveness (Phase 2)UnknownNCT02924909
What this trial is testing

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer

Who this might be right for
Esophageal CancerInduction Chemotherapy
Instituto Nacional de Cancer, Brazil 50
Large-scale testing (Phase 3)Looking for participantsNCT04447352
What this trial is testing

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Krankenhaus Nordwest 200
Next Page